Virginia LeBaron, APRN, PhD, FAAN, post-doctoral research fellow, Dana-Farber Cancer Institute, discusses a study that looked at how cancer outpatients and health care providers talk about pain.
Dr. Clayton Lau, a prostate cancer expert, discusses the options for patients with early-stage prostate cancer and the importance of staying educated on this disease.
A clinical look at cannabis as a treatment option for patients with cancer.
Bart C. De Jonghe, PhD, assistant professor, School of Nursing, University of Pennsylvania, discusses inflammation, obesity and cancer.
Advancements in CAR-T cell therapy are changing the way many cancers are being treated.
Jeannine Brant, PhD, Billings Clinic, discusses the benefits of patient-reported outcomes in cancer care.
Electronic health records (EHR), which have been found to improve care and management of multiple chronic diseases in older adults, could also be customized to improve cancer screening rates in this population by integrating recommended screening protocols based on age, family history and other environmental, occupational, and behavioral risk factors (ie, smoking and alcohol use).
Colleen O'Leary, MSN, RN, AOCNS, discusses how nurses and physicians can communicate with one another better.
Kara Maxwell, MD, PhD, instructor, medical oncologist, Basser Research Center for BRCA, University of Pennsylvania, discusses the need to personalize the treatment of breast cancer.
Mary McCabe, RN, MA, director of the Cancer Survivorship Center at Memorial Sloan Kettering (MSK) Cancer Center, discusses how nurse practitioners are becoming increasingly important in survivorship care for patients who are finished with their cancer treatment.
Loretta Muss, coordinator, Patient and Family Advisory Board, co-chair, Partnering with Patients and Families, University of North Carolina Lineberger Comprehensive Cancer Center, North Carolina Cancer Hospital, discusses patient and family centered care.
Applying 4 philosophies to the nurse case manager role can assist with patient decision making.
Mary Ann Caputo, executive director, Support for People with Oral and Head and Neck Cancer (SPOHNC), discusses services offered by the foundation for patients, caregivers, and their families.
From long-term data to additional clinical trials, more is needed to better understand immunotherapy in lung cancer.
The occurence of hand-foot skin response could signal regorafenib activity in hepatocellular cancer.
James L. Klosky, PhD, director or psychological services and cancer survivorship, St. Jude Children’s Research Hospital, discusses HPV-related complications, including cancer, for survivors of childhood cancer.
Although we as healthcare providers want to be cautious and not provide a sense of false hope, we can also acknowledge that for individuals who are deeply religious and spiritual, terminal illness that results in death may not be viewed as negative.
Ian R. Kleckner, PhD, Research Assistant Professor at University of Rochester Medical Center, discusses the benefits of exercise for patients with chemotherapy-induced peripheral neuropathy (CIPN).
About 60% of adult patients with cancer experience constipation, but oncology nurses can help.
Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the universality of psychosocial concerns following a cancer diagnosis.
Jacquelyn Lauria, RN, MSN, APN-C, AOCNP, Advanced Practice Nurse, Stacey Goldstein Breast Cancer Center, Rutgers Cancer Institute of New Jersey, discusses the importance of including a cancer survivor's primary care doctor in the survivorship care plan.
Improvements in cancer treatment have increased survival rates, and with more patients being diagnosed with cancer, complexity of disease state, and treatment toxicity, it can be challenging to identify an appropriate care delivery model.
K. Kelly Hancock, MSN, RN, NE-BC, Executive Chief Nursing Officer, Cleveland Clinic Health System, discusses coordination of care by nurse navigators.
Do a head-to-toe scan when discussing adverse events for melanoma treatment, says a nurse practitioner.
Research shows that not addressing the contributing factors of financial toxicity creates distress, anxiety, and depression and threatens a patient’s optimum health.
Dr. Jeffrey Weber describes the organ-specific side effects that can occur in a patient on checkpoint inhibitors.